KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Charles River Laboratories International (CRL) EBIT Margin: 2009-2025

Historic EBIT Margin for Charles River Laboratories International (CRL) over the last 17 years, with Sep 2025 value amounting to 13.32%.

  • Charles River Laboratories International's EBIT Margin rose 169.00% to 13.32% in Q3 2025 from the same period last year, while for Sep 2025 it was 3.50%, marking a year-over-year decrease of 950.00%. This contributed to the annual value of 5.61% for FY2024, which is 933.00% down from last year.
  • Charles River Laboratories International's EBIT Margin amounted to 13.32% in Q3 2025, which was up 37.25% from 9.70% recorded in Q2 2025.
  • Charles River Laboratories International's 5-year EBIT Margin high stood at 19.26% for Q2 2022, and its period low was -16.73% during Q4 2024.
  • Its 3-year average for EBIT Margin is 10.23%, with a median of 13.12% in 2023.
  • As far as peak fluctuations go, Charles River Laboratories International's EBIT Margin soared by 422bps in 2022, and later slumped by 2,984bps in 2024.
  • Quarterly analysis of 5 years shows Charles River Laboratories International's EBIT Margin stood at 19.09% in 2021, then tumbled by 420bps to 14.89% in 2022, then plummeted by 178bps to 13.12% in 2023, then plummeted by 2,984bps to -16.73% in 2024, then skyrocketed by 169bps to 13.32% in 2025.
  • Its EBIT Margin was 13.32% in Q3 2025, compared to 9.70% in Q2 2025 and 7.59% in Q1 2025.